Evidence-based dry-eye therapies for clinical use
8 October 2021
Volume 22, Issue 3
This article outlines a range of dry-eye disease management strategies available at each severity level and between subtypes of the disease.
Domains covered
Professionalism
Clinical practice
Specialty CPD (IP)
Despite recent advances in the management and treatment of dry-eye disease, the condition is still managed differently across continents and countries. From diagnosis to disease progression and treatment, patients should be well informed about the safe and effective use of available therapies. Consequently, this article aims to appraise eye care practitioners of a wide range of management strategies available at each severity level and between subtypes of dry-eye disease.
Sign in to view the article
Not a member? Start enjoying the benefits of College membership today. Take a look at what the College can offer you and view our membership categories and rates.
Related further reading
Many people suffering from hypertension don’t even know they have a problem. But in the right setting, writes Léa Surugue, Optometrists can be part of the solution.
Ocular cancers are uncommon but serious. Thankfully, there are world-class specialist centres here in the UK. Carina Bailey looks into the service they provide.
John Windell asks whether more practices should consider adding the specially designed night-time RGP lenses to their portfolios.